Compare GEMI & THW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | GEMI | THW |
|---|---|---|
| Founded | 2014 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Finance Companies |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 666.3M | 565.9M |
| IPO Year | 2025 | 2015 |
| Metric | GEMI | THW |
|---|---|---|
| Price | $5.74 | $13.42 |
| Analyst Decision | Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $8.31 | N/A |
| AVG Volume (30 Days) | ★ 2.7M | 95.2K |
| Earning Date | 05-14-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 51.86 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $179,572,000.00 | N/A |
| Revenue This Year | $35.05 | N/A |
| Revenue Next Year | $39.56 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 26.31 | N/A |
| 52 Week Low | $3.39 | $11.18 |
| 52 Week High | $26.75 | $14.50 |
| Indicator | GEMI | THW |
|---|---|---|
| Relative Strength Index (RSI) | 65.09 | 41.70 |
| Support Level | $3.92 | $13.00 |
| Resistance Level | $6.96 | $13.53 |
| Average True Range (ATR) | 0.40 | 0.24 |
| MACD | 0.05 | -0.09 |
| Stochastic Oscillator | 96.75 | 14.74 |
Gemini Space Station Inc is engaged on unlocking the next era of financial, creative, and personal freedom. It envisions a future where crypto will redesign the global financial system, the internet, and money in a way that provides greater choice, independence, and opportunity for all. As a trusted bridge between the traditional financial system and the emerging crypto economy, It is providing access for individuals and institutions to a decentralized future that is more open, fair, and secure. Its core exchange product has expanded over time to become a comprehensive platform for its users to engage with the crypto economy, including a derivatives exchange, staking services, an over-the-counter (OTC) trading desk, institutional-grade custody, and others.
Tekla World Healthcare Fund is a diversified closed-end management investment company. Its investment objective is to seek current income and long-term capital appreciation. The Fund mainly invests in equity and debt securities of public and private U.S. and non-U.S. companies that the Fund's investment adviser believes have the potential for above-average growth. The company's investment portfolio includes holdings across various sub-sectors such as pharmaceuticals and biotechnology, healthcare providers and services, real estate investment trusts, medical devices and diagnostics, and other related areas.